Cutler Group LP Athenex, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Jul 19, 2021	SELL	$3.71 - $5.13 $13,727 - $18,981	-3,700 Reduced 97.37%	100 $0
Q1 2021 Apr 26, 2021	BUY	$4.08 - $14.75 $14,280 - $51,625	3,500 Added 1166.67%	3,800 $0
Q4 2019 Feb 06, 2020	SELL	$9.6 - $17.75 $9,600 - $17,750	-1,000 Reduced 76.92%	300 $0
Q3 2019 Oct 28, 2019	BUY	$12.16 - $21.0 $3,648 - $6,300	300 Added 30.0%	1,300 $0
Q2 2019 Aug 09, 2019	BUY	$9.44 - $19.8 $9,440 - $19,800	1,000 New	1,000 $3,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.